ArticleJAMA network open2026

Skin Toxic Effects and Survival With Enfortumab Vedotin-Pembrolizumab in Advanced Urothelial Carcinoma.

Zachariah Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.